About Organon & Co. 
Organon & Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 95 Schemes (45.97%)
Foreign Institutions
Held by 220 Foreign Institutions (10.28%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,460 Million
(Quarterly Results - Mar 2026)
Net Profit:
146 Million
Pharmaceuticals & Biotechnology
USD 1,520 Million (Small Cap)
3.00
NA
1.02%
10.78
69.90%
2.02






